Epibiotech Co., Ltd. (XKON:446440)
South Korea · Delayed Price · Currency is KRW 9,540.00
-1,680.00 (-14.97%)
At close: Nov 12, 2026
Epibiotech Market Cap
Epibiotech has a market cap or net worth of 22.01 billion as of November 13, 2026. It is the 38,057th most valuable company in the world and the 2,321st biggest in South Korea. Its market cap has decreased by 39.20% in one year.
Market Cap
22.01B
Enterprise Value
n/a
Revenue
449.62M
Global Rank
Country Rank
#2,321 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since July 31, 2023, Epibiotech's market cap has decreased from 58.59B to 22.01B, a decrease of -62.44%. That is a compound annual growth rate of -25.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 22.01B | -36.40% |
| Dec 30, 2025 | 34.60B | -2.83% |
| Dec 30, 2024 | 35.61B | 24.00% |
| Dec 28, 2023 | 28.72B | -50.98% |
| Jul 31, 2023 | 58.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Quratis | 41.40B |
| Kainos Medicine | 35.56B |
| Eutilex.Co.,Ltd | 35.32B |
| HLB Pep | 31.36B |
| Progen | 27.68B |
| Poongjeon Pharmacy CO.,LTD. | 20.47B |
| ADBiotech | 19.62B |
| Shaperon | 19.05B |